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In the lactating mammary gland, weaning produces mitochondrial
cytochrome c release and nuclear DNA fragmentation, as deter-
mined by gel electrophoresis. This is followed by a significant
decrease in lactation. Weaning for 2 h produces an early induc-
tion of the tumour suppressor/transcription factor p53, whereas
the oncoprotein c-Jun and c-Jun N-terminal kinase are elevated
after 24 h of weaning when compared with controls. The expres-
sion of p21cip1 and p27kip1, cyclin-dependent kinase inhibitors, was
significantly higher in weaned rats when compared with control
lactating rats. All the changes mentioned above also happen in
the lactating mammary gland when propargylglycine, an inhibitor
of the liver trans-sulphuration pathway, is administered. This
effect is partially reversed by N-acetylcysteine administration.
The administration of buthionine sulphoximine, an irreversible
inhibitor of γ -glutamylcysteine synthetase, to lactating rats
produces a decrease in GSH levels and changes in protein
concentrations and gene transcripts similar to those in rats with
impaired trans-sulphuration pathway. These data suggest that
the inter-tissue flux of GSH is an important mechanism of L-
cysteine delivery to the lactating mammary gland and emphasize
the importance of this physiological event in maintaining the gene
expression required to sustain lactation.
Key words: apoptosis, γ -cystathionase, L-cysteine, glutathione
(GSH), lactation.
INTRODUCTION
During lactation there are changes in the metabolism of different
tissues to ensure a supply of substrates to the mammary
gland for milk production. These changes are accompanied by
several physiological adaptations, such as hyperphagia, liver
and mammary-gland hypertrophy, increased cardiac output and
increased blood flow to the gland. In liver, γ -cystathionase expres-
sion and activity are significantly higher in lactating rats than
in control rats [1,2]. This enzyme catalyses the synthesis of L-
cysteine in the liver, and the availability of this amino acid is rate-
limiting for GSH synthesis [3]. This tripeptide is then released
to plasma and directed to those tissues with high γ -glutamyl-
transpeptidase (GGT) activity. During lactation, the mammary
gland has a high GGT activity, which, together with the increased
blood flow to the gland and the hypertrophy, makes the mammary
gland the organ with greatest GSH utilization [2]. This inter-
tissue flux of GSH serves as the primary source of L-cysteine to
the mammary gland, because the trans-sulphuration pathway is
not expressed in this tissue.
Mammary-gland involution is a physiological process that takes
place at the end of lactation and it is characterized by (i) metabolic
changes, (ii) cessation of milk-protein gene expression, (iii) pro-
grammed cell death (PCD) of secretory epithelial cells and
(iv) tissue remodelling and preparation of the gland for a new
pregnancy. The most important signals in the initiation of this
cascade of modifications in the mammary epithelium seem to be
milk stasis and hormonal changes when pups stop suckling [4,5].
Abbreviations used: AP-1, activator protein-1; BSO, buthionine sulphoximine; GGT, γ-glutamyltranspeptidase; NAC, N-acetylcysteine; PCD, programmed
cell death; (p-) JNK, (phosphorylated) c-Jun N-terminal kinase; PPG, propargylglycine; RT-, reverse transcription; 26S RIB, 26 S ribosomal protein; Stat3,
signal transduction and activators of transcription 3.
1 To whom correspondence should be addressed (e-mail juan.r.vina@uv.es).
Oxidants are commonly thought to trigger apoptosis. Recently
a link has been shown between GSH oxidation during mammary-
gland involution and induction of apoptosis, leading to the
speculation that GSH loss may be an important early event in
the cell-death pathway [6,7].
To study the role of L-cysteine as a precursor of GSH in
the mammary gland during lactation we used rats injected
with propargylglycine (PPG), a specific inhibitor of the γ -
cystathionase [8]. In these rats the GSH released from the liver
is diminished, and so is the delivery of GSH to the lactating
mammary gland; this is accompanied by a significant decrease in
lactation, even though the ectoenzyme GGT is not inhibited [2,9].
To characterize the changes produced by the injection of PPG, we
focused the present study on the genes that appeared to be induced
within a few hours of weaning, and we found that most of them
were also induced at this time. PPG treatment of lactating rats
induces an increase in apoptosis in the mammary gland similar to
the results found in weaned rats.
In conclusion, GSH delivery to the lactating mammary gland is
essential for the maintenance of lactation, and its decrease leads
to apoptosis and involution of the mammary tissue. Treatment of
rats with N-acetylcysteine (NAC) blunted the effects of PPG on
mammary involution. To confirm our hypothesis, another group of
rats was treated with buthionine sulphoximine (BSO), a potent and
specific inhibitor of γ -glutamylcysteine synthetase. Treatment
with BSO decreased GSH levels in several organs, including
mammary gland and liver. Decreased concentrations of GSH
induced apoptosis in the lactating mammary gland, and changes
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in gene expression that were similar to those observed in response




Female Wistar rats were kept on individual cages on a 12 h
light/12 h dark cycle, had free access to water and were fed
ad libitum. Rats were cared for and handled in conformance
with the National Institutes of Health guidelines and the Guiding
Principles for Research Involving Animals and Humans approved
by the Council of The American Physiological Society. The
Research Committee of the School of Medicine (University of
Valencia, Valencia, Spain) approved the study protocol. Following
parturition, litters were maintained with at least ten pups. Rats
were anaesthetized intraperitoneally with sodium pentobarbital
(Abbott Laboratories, S.A., Madrid, Spain; 60 mg · kg body wt.−1
in 0.9% NaCl) and the tissues were extracted. Once sampling
was finished, sodium pentobarbital (1 ml of a 150 mg/ml
solution) was injected through the left femoral vein. This dose was
sufficient to stop the heart within 2–3s.
For control lactating rats, inguinal mammary glands were
isolated at the peak of lactation (days 12–15). In the case of
weaned rats, pups were removed 12 days after delivery to initiate
involution; the weaning took place for 2, 4, 8, 24 and 72 h
before the animals were killed and then inguinal mammary glands
were isolated. At least three rats for each condition were used.
To evaluate the impact of inhibiting the trans-sulphuration
pathway in liver on lactation and apoptosis in the mammary gland,
lactating rats were treated with PPG and NAC. One group of
eight rats on day 12 of lactation was injected with PPG (Sigma
Chemical Co., St Louis, MO, U.S.A.) over a period of 3 days
(50 mg · day−1 · kg−1, intraperitoneally); a second group of nine
rats was treated simultaneously with PPG (50 mg · day−1 · kg−1)
and NAC (80 mg · kg−1 three times a day), obtained from the
Pharmacy Unit of our Medical School and was originally from
Zambo´n (Sta Perpetua De Mogoda, Barcelona, Spain); lastly a
third group of seven rats at the peak of lactation was injected with
NAC only (80 mg · kg−1, three times a day) to discard the effects
due to this component. To study the effect of PPG on the litter (in
case it was transferred through milk consumption) and to rule out
the possibility that inhibition of the trans-sulphuration pathway
could decrease milk removal, pups were cross-fostered after each
daily PPG injection, so that all dams fostered control pups. The
experiment was done as follows: 24 h after each administration
of PPG, pups were weighed and switched from the PPG-treated
rat to a control lactating rat and vice versa.
Another set of four rats was treated with BSO (Sigma) over a
period of 2 days (4 mmol · kg−1, twice a day intraperitoneally) to
decrease GSH levels.
GSH determination
The freeze-clamped tissue was powered in liquid nitrogen with a
pestle and a mortar, and a portion of the powder (about 1 g) was
extracted with 4 vol. (v/w) of 6%HClO4 by homogenization with
a motor-driven Teflon homogenizer. The extract was centrifuged
at 1500 g for 10 min to remove proteins, and the final supernatant
was used to measure GSH using the glutathione S-transferase
(EC 2.5.1.18) method [10].
Measurement of γ -cystathionase activity
The activity of this enzyme (EC 4.4.1.1) was measured by deter-
mining the rate of L-cysteine synthesis from cystathionine [11].
Briefly, the tissue was homogenized in ice-cold 30 mM potassium
phosphate buffer, pH 6.9. Homogenates were centrifuged at
28 000 g for 30 min, and the supernatant fluid was was assayed.
The reaction mixture for the assay of cystathionase activity
contained 2 mM L-cystathionine (Sigma), 0.53 mM pyridoxal 5′-
phosphate (Sigma) in 0.1 M potassium phosphate buffer, pH 6.9.
A 1 ml portion of this cocktail was added to 250 µl of sample,
which was incubated at 37 ◦C for 0, 15 and 30 min. Then 125 µl
of 20% HClO4 was added to stop the reaction; under these
conditions the rate of formation of cysteine was linear with time.
Dithiothreitol (10 mM; Sigma) was added to bring all cysteine
into the reduced form, and the amount of cysteine was determined
by the spectrophotometric method of Gaitonde [12].
Measurement of γ -GGT activity
γ -GGT activity was measured by monitoring the reaction of γ -
glutamine p-nitroanilide (Sigma) as a substrate of GGT hydro-
lytic activity and glycylglycine as glutamate acceptor for the
transpeptidation reaction, as described previously [13].
Milk production
Sampson and Jansen [14] developed a simple method that permits
estimation of daily milk yield in the well-nourished dam from pup
weight and weight gain. The following equation relating pup milk
yield to pup weight and weight gain was used to estimate milk pro-
duction:
Yield = 0.0322 + 0.0667 (weight) + 0.877 (gain)
where yield is daily yield per pup (g/day per pup), weight is pup
weight (g) and gain is pup daily weight gain (g/day).
DNA fragmentation
After weaning, one of the earliest changes denoting cell death
is the activation of a calcium-dependent endonuclease and asso-
ciated DNA fragmentation [15]. DNA was extracted as follows:
0.1 mg of tissue was homogenized with 1 ml of lysis buffer con-
taining 100 mM Tris/HCl, pH 7.5, 10 mM EDTA, 10 mM NaCl,
0.4 mg/ml proteinase K (Roche Diagnostics GmbH, Mannheim,
Germany) and 0.5%SDS. The solution was incubated at 50 ◦C for
3 h. The DNA was purified by phenol/chloroform/3-methylbutan-
1-ol (25:24:1, by vol.; Sigma) extraction, precipitated with
95% (v/v) ethanol, washed, dried and dissolved in 200 µl of TE
buffer [10 mM Tris/HCl (pH 7.5)/1 mM EDTA]. Then it was
treated at 37 ◦C for 2 h with 0.2 mg/ml DNase-free RNase
(Roche) and quantified spectrophotometrically at 260 nm. After
electrophoresis on 3%-(w/v)-agarose gel, the proteins in the gel
were revealed by staining with ethidium bromide.
RNA isolation and reverse-transcription (RT)-PCR
For RT-PCR total RNA was isolated from individual mammary
glands using guanidinium thiocyanate/phenol/chloroform extrac-
tion [16]. Equal amounts of RNA (2 µg) were used in the RT
reaction, using oligo(dT)23 (Sigma) as the primer, to generate
the first-strand cDNA and SuperScriptTM reverse transcriptase
(200 units/µl) (Invitrogen Life Technologies, Frederick, MD,
U.S.A.), following the instructions of the manufacturer.
The cDNA was used as a template for amplification in PCR;
we used 2 µl of the first-strand reaction for PCR. The PCR ana-
lysis for the different genes was performed using Biotools DNA
polymerase gel-form from B&M Laboratories, S.A. (Madrid,
Spain). The conditions for each PCR were determined in
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Table 1 γ -Cystathionase and γ -GGT activities and concentration of GSH in liver and mammary gland of control lactating rats and lactating rats injected with
PPG, NAC, or both
Results are means +− S.E.M with the numbers of rats in parentheses. Different superscript letters within a row indicate significant differences, P < 0.05. ND, not detectable.
Organ Control + PPG, 3 days + PPG + NAC, 3 days + NAC, 3 days
Liver
GSH (µmol/g) 5.8 +− 0.4 (11)b 3.2 +− 0.5 (8)a 5.9 +− 1.1 (9)b 7.6 +− 0.3 (7)b
γ -Cystathionase [µmol/(g · min)] 0.39 +− 0.02 (9)a ND ND 0.37 +− 0.03 (7)a
Lactating mammary gland
GSH (µmol/g) 2.3 +− 0.2 (13)ab 1.5 +− 0.2 (8)a 2.3 +− 0.3 (8)ab 2.8 +− 0.2 (7)b
γ -Cystathionase (µmol/min per g) ND ND ND ND
γ -GGT (µmol/min per g) 11.0 +− 0.3 (4)a 10.7 +− 0.9 (4)a 9.0 +− 0.4 (4)a 8.9 +− 0.5 (4)a
preliminary experiments and optimized for each set of primers.
Expression levels of the tumour suppressor/transcription factor
p53 were determined using the following specific primers (5′ to
3′): CACAGTCGGATATGAGCATC and GTCGTCCAGATACT-
CAGCAT; primers for p21 (5′ to 3′) were: GTGAGACACCAG-
AGTGCAAGA and ACAGCGATATCGAGACACTCA; specific
primers for the oncoprotein c-Jun (5′ to 3′) were: TGAGTGCA-
AGCGGTGTCTTA and TAGTGGTGATGTGCCCATTG. To
amplify the 26 S ribosomal protein (26S RIB) the following
primers (5′ to 3′) were used: AATTCGCTGCACGAACTGCG
and CAGCAGGTCTGAATCGTGGT. The amplification con-
ditions were one cycle at 85 ◦C for 2 min and one cycle at
94 ◦C for 2 min. Then for p53, 35 cycles of denaturation (94 ◦C
for 30 s), annealing (58 ◦C for 30 s) and extension (70 ◦C for
1 min) with a final extension of 70 ◦C for 10 min were used; the
differences among the different amplifications were with regard
to the number of cycles and the annealing temperature so that:
for c-Jun, there were 40 cycles and the annealing temperature
was 54 ◦C; for p21 there were 35 cycles and the annealing
temperature was 62 ◦C; and for 26S RIB there were 25 cycles
and the annealing temperature was 51 ◦C. The resulting PCR
products were separated by electrophoresis in a 1.5%-(w/v)-
agarose gel in TBE (90 mM Tris/90 mM boric acid/2 mM EDTA,
pH 8.0) and stained with ethidium bromide. The expected sizes
for the PCR products were: 26S RIB (252 bp), p53 (600 bp), c-Jun
(461 bp) and p21 (400 bp). In this semi-quantitative method the
intensity of the bands was measured by densitometry using
the GeneGenius system and the GeneTools analysis software
(Syngene, Cambridge, U.K.).
Immunoblot analysis
Tissues were homogenized in 10 ml of ice-cold buffer A [20 mM
Hepes (pH 7.9)/20% (v/v) glycerol/250 mM KCl/2 mM MgCl2/
0.2 mM EDTA/0.5 mM dithiothreitol/1 mM PMSF/5 mM NaF/
0.5 mM Na3VO4/0.1% Triton X-100] in the presence of protease
inhibitors (5 µl/ml of buffer of protease inhibitor cocktail from
Sigma)/g of tissue. The resulting homogenate was centrifuged at
500 000 g for 15 min at 4 ◦C.
To analyse cytochrome c release from mitochondria, cytosol
extracts were obtained from mammary tissue by differential
centrifugation as follows: tissues were homogenized in 10 ml
of ice-cold buffer B [10 mM Hepes (pH 7.9)/10 mM KCl/
2 mM MgCl2/0.5 mM dithiothreitol/1 mM PMSF/5 mM NaF/
0.5 mM Na3VO4/0.1% Triton X-100] in the presence of protease
inhibitors)/g of tissue. Then the homogenate was centrifuged at
800 g for 10 min at 4 ◦C. The resulting supernatant was centri-
fuged at 20 000 g for 15 min at 4 ◦C. The pellet was discarded and
the supernatant was used to analyse cytosol proteins.
Mammary homogenates were normalized for protein con-
centration using the BCA (bicinchoninic acid) protein assay
reagent (Pierce Chemical Co., Rockford, IL, U.S.A.). Equal
amounts of protein (25 µg) were then boiled in sample buffer
for 5 min and separated by SDS/PAGE. After electrophoresis, the
proteins were transferred to 0.2-µm-pore-size nitrocellulose. For
all antibodies, the membranes were incubated in blocking solution
[5% (w/v) non-fat dry milk with 0.05% (v/v) Tween 20], for
1 h at room temperature with shaking; following three washes
with TTBS [25 mM Tris/HCl (pH 7.5)/0.15 M NaCl/0.1% (v/v)
Tween 20], blots were incubated with primary antibodies [p53,
p21 and p27 monoclonal mouse antibodies were purchased from
Calbiochem, La Jolla, CA, U.S.A.; cytochrome c, phosphorylated
c-Jun N-terminal kinase (p-JNK) and c-Jun were from Santa
Cruz Biotechnology, Santa Cruz, CA, U.S.A.] in TTBS for 1 h
at room temperature. Blots were washed again with TTBS and
incubated with the secondary antibody conjugated to horseradish
peroxidase (Santa Cruz) for 60 min at room temperature. Finally,
blots were washed with TTBS and detection was carried out
using the chemiluminescent luminol reagent (Supersignal West
Pico; Pierce). The intensity of the bands was measured by
densitometry using the GeneGenius system and the GeneTools
analysis software (Syngene).
Statistics
In Tables 1 and 2 below and in the bar graphs of Figures 3, 4,
5 and 6 below, ANOVA was performed. The homogeneity of
the variances was analysed by the Levene test. The null
hypothesis was accepted for all the values of these sets in which
the F-value was non-significant at P > 0.05. The data for which the
F-value was significant were examined by Tukey’s test at
P < 0.05.
RESULTS
γ -Cystathionase and γ -GGT activities and GSH concentration in
liver and mammary gland from lactating rats, PPG-treated
lactating rats and PPG-treated rats injected with NAC
As seen in Table 1, liver γ -cystathionase activity was undetectable
in PPG-treated lactating rats when compared with control lac-
tating rats because this compound is an irreversible inhibitor of the
enzyme. When PPG and NAC were injected simultaneously,
the activity remained undetectable; the injection of NAC into
control lactating rats did not change the enzyme activity in liver.
The γ -cystathionase activity in lactating mammary gland was
undetectable under all situations studied, confirming that the trans-
sulphuration pathway is not expressed in this tissue.
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Table 2 Daily milk production in lactating rats under different experimental
conditions
(a) Daily milk production in untreated lactating rats and lactating rats injected with PPG, NAC, or
both. Results are means +− S.E.M.. There were ten pups/dam. Different superscript letters within
a row indicate significant differences, P < 0.05. (b) Daily milk production in lactating rats and
lactating rats injected with PPG after cross-fostering of pups. Results are means +− S.E.M. with
the number of rats in parentheses. Different superscript letters within a row indicate significant
differences, P < 0.05. ND, not detectable.
(a)
Milk production (ml/pup)
Dam Control (5) + PPG (5) + PPG + NAC (5) + NAC (6)
Previous day 3.0 +− 0.1a 3.3 +− 0.3a 2.9 +− 0.1a 3.0 +− 0.2a
24 h 3.2 +− 0.1a 2.2 +− 0.3a 2.4 +− 0.2a 3.1 +− 0.2a
48 h 3.2 +− 0.1ab 2.1 +− 0.1a 2.3 +− 0.4a 3.3 +− 0.2b
72 h 3.3 +− 0.2b 1.3 +− 0.3a 2.2 +− 0.4ab 3.2 +− 0.2b
(b)
Milk production (ml/pup)
Dam Control (3) +PPG (3)
Previous day 2.9 +− 0.2a 2.8 +− 0.2a
24 h 3.5 +− 0.2a 2.1 +− 0.5a
48 h 3.3 +− 0.2b 1.1 +− 0.4a
72 h 4.2 +− 0.4b 0.8 +− 0.2a
The γ -GGT activity in the lactating mammary gland was not
affected by the administration of PPG (Table 1), but was sig-
nificantly lower after the removal of the pups (results not shown).
Liver GSH concentration was significantly lower in PPG-
treated lactating rats than in control lactating rats. The admin-
istration of NAC to PPG-treated lactating rats restored
the concentration of liver GSH to control values (Table 1). The
GSH concentration in the mammary gland of PPG-treated rats
was significantly lower than in control lactating rats and in
rats injected with NAC (Table 1).
Inhibition of liver γ -cystathionase activity decreases lactation and
is reversed by NAC
Table 2(a) shows that inhibition of liver γ -cystathionase activity
by PPG injection over a period of 3 days produced an inhibition
of lactation that was reflected in low milk production compared
with control lactating rats. This difference was significant 48 h
after injection of PPG. When rats were injected simultaneously
with PPG and NAC over a period of 72 h, this decrease was
prevented. NAC injection to control lactating rats did not modify
milk production [2] (See Table 2a).
To evaluate the possibility that inhibition of the trans-sul-
phuration pathway could decrease growth and vitality in pups and
consequently they could provide reduced suckling stimuli
and milk removal, cross-fostering of pups was done so that all
dams fostered control pups. This cross-fostering did not impel the
decrease in milk production, as shown in Table 2(b).
Apoptosis is induced in lactating mammary gland by litter removal
or by the inhibition of liver trans-sulphuration pathway by PPG
treatment
Release of cytochrome c from mitochondria is a common marker
of apoptosis [15]. Figure 1 shows that weaning for 2 h resulted in
the release of this protein to cytosol. Similar results were found
when analysing cytosol extracts from mammary tissue of PPG-
Figure 1 Protein concentrations of cytochrome c in cytosolic extracts from
mammary-gland homogenates
(A) At different times after the removal of pups [2, 4, 8, 24 and 72 h of weaning (’2h W’ etc.)],
mammary tissue was isolated and cytosol extracts were obtained. Western immunoblot analysis
of cytochrome c was performed. (B) Cytosol extracts from lactating mammary gland of PPG-,
PPG + NAC- and NAC-treated rats were prepared for the same immunoblot analysis. This Figure
shows a representative experiment. 3d, 3 days.
Figure 2 DNA fragmentation in the mammary gland
Agarose-gel electrophoresis of DNA from (A) mammary gland after different times of litter
removal [control lactating rats and rats weaned for 2, 4, 8, 24 or 72 h (’2h W’ etc.)] or (B) from
lactating mammary tissue obtained from lactating rats injected with PPG, NAC, or both, over a
period of 3 days. This Figure shows a representative experiment.
treated rats. It is noteworthy that NAC administration to
PPG-treated rats did not reverse the trend of cytochrome c release.
Lactating rats were weaned for 2, 4, 8, 24 and 72 h. Failure
of milk removal from the gland induced PCD after 24 h of pup
removal. As Figure 2(A) shows, this PCD was characterized by an
increased activation of the apoptosis-specific endonuclease which
led to a ladder-type DNA pattern of nuclear apoptosis in the
mammary gland. Figure 2(B) shows that, when control lactating
rats were injected with PPG over a period of 3 days, an apoptotic
pattern similar to that seen for mammary gland after weaning was
obtained. The simultaneous administration of NAC and PPG to
control lactating rats over a period of 3 days showed a lower rate
of apoptosis when compared with rats injected with PPG alone.
NAC by itself did not produce any change at all, and the pattern
was the same as that shown by control lactating rats.
Effect of weaning on JNK, c-Jun, p53, p21 and p27 expression in
rat mammary gland
p53 plays a pivotal role during weaning; the amount of p53 mRNA
and protein levels were studied in the mammary gland from
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Figure 3 RT-PCR analysis of c-Jun, p53 and p21 in mammary gland during weaning
RT-PCR analysis of whole RNA isolated from mammary gland was used to examine the transcription of c-Jun, p53 and p21 from control lactating rats (control) and at different times of weaning (W).
Three rats for each condition were employed for semi-quantitative analysis. The graphs show the ratio of each gene to 26S RIB; results are means +− S.E.M. Different superscript letters within a row
indicate significant differences; P < 0.05.
control lactating rats and rats under different times of weaning. As
Figures 3 and 4 show, the steady-state mRNA levels of p53 and
protein concentrations respectively increased more than threefold
2 h after weaning when compared with controls. Interestingly this
increase was not constant; at 4 and 8 h after weaning the fold
change was lower than at 2 h, and then, at 24 h after weaning, the
levels rose again.
The transcript levels of c-Jun, which is upstream of p53, did
not change after 4 h of weaning (Figure 3), but the amounts of
c-Jun and JNK (a kinase that directly regulates c-Jun) protein
were significantly increased 24 h after the removal of pups when
compared with control values and remained elevated at 72 h after
weaning (Figure 4).
p53 is known to induce the expression of the p21cip1, which
belongs to a family of proteins that regulate cell-cycle arrest
[17]. The steady-state amounts of mRNA (Figure 3) and protein
(Figure 4) of p21cip1 were significantly increased during weaning
when compared with control lactating rats. Since p21cip1 is a target
of p53, it was not surprising to find that there was also a fluctuation
in the increase of this gene; as with p53, there was a pronounced
increase 2 h after weaning; weaning then for 4 and 8 h resulted in
a lower fold change of p21cip1; it increased again at 24 and 72 h.
Similar results were obtained when the protein p27kip1, another
cyclin-dependent kinase inhibitor from the same family, was
studied. As seen in Figure 4, the levels of this protein increased
when the weaning took place.
Effect of the inhibition of liver trans-sulphuration pathway by PPG
on JNK, c-Jun, p53, p21 and p27 expression in rat lactating
mammary gland
p53 was analysed in lactating rats injected with PPG over a period
of 3 days and in lactating rats injected with PPG and NAC over
a period of 3 days. The amounts of p53 mRNA (Figure 5) and
protein (Figure 6) in the mammary gland from PPG-treated rats
were increased twofold when compared with rats at the peak of
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Figure 4 Western-blot analysis of p-JNK, c-Jun, p53, p21 and p27 from weaned mammary gland
Western-blot analysis of proteins extracted from mammary glands (50 µg of protein/lane). Total extract from control lactating rats at the peak of lactation (control) and after different periods of
involution [2, 4, 8, 24 and 72 h weaning (’2h W’ etc.] were analysed by Western blot for phosphorylated JNK, c-Jun, p53 and the Cip/Kip proteins p21cip1 and p27kip1. Results are means +− S.E.M.
Different superscript letters within a row indicate significant differences, P < 0.05.
lactation. This pattern was similar to that exhibited by weaned-pup
glands. The administration of NAC to PPG-treated rats prevented
the increase of p53 transcripts, although the amount of protein
was slightly higher than in controls.
Administration of PPG over a period of 3 days to lactating
rats also increased the transcription of c-Jun (Figure 5), but
when NAC was administered simultaneously, the increase was
prevented. Protein amounts of JNK and c-Jun were higher after
PPG administration (Figure 6). Administration of NAC to PPG-
treated rats partially prevented the increase in the levels of these
proteins.
When studying the steady-state mRNA (Figure 5) and the
protein levels (Figure 6) of p21cip1 in PPG-treated rats, the results
showed that inhibition of the trans-sulphuration pathway also
produced an increase in p21cip1 expression similar to that shown
by weaned rats. The administration of NAC appeared to maintain
p21cip1 transcripts at control levels, although protein levels were
higher than those of controls.
Treatment of rats with PPG over a period of 3 days also resulted
in higher levels of p27kip1 protein (Figure 6), but the administration
of NAC partially reversed this increase.
BSO injection to rats at the peak of lactation reduces GSH
availability to the mammary gland, reproducing gene and
protein changes seen for PPG treatment
BSO is a potent and specific inhibitor of γ -glutamylcysteine
synthetase; administration of BSO over a period of 2 days
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Figure 5 RT-PCR analysis of c-Jun, p53 and p21 in control lactating rats and rats treated with PPG, NAC or both
Total RNA was isolated from lactating tissue (control) or mammary gland from rats treated with PPG, PPG + NAC or NAC for 3 days and amplified by RT-PCR as described in the Experimental
section. The graphs show the ratio of p53 and p21 to 26S RIB for each experimental condition. The results shown are representative of three independent experiments for the semi-quantitative
analysis; results are means +− S.E.M. Different superscript letters within a row indicate significant differences, P < 0.05.
resulted in a significant decrease in GSH level in the liver
[control 5.8 +− 0.4 µmol/g of tissue (11) and BSO-treated rats:
1.1 +− 0.1 (P < 0.05) µmol/g of tissue (3)] and in mammary gland[Control values were 2.3 +− 0.2 µmol/g of tissue (12) and BSO-
treated rats 0.4 +− 0.1 (P < 0.05) µmol/g of tissue (3)]. Results are
expressed as means +− S.E.M.
The γ -GGT activity in the lactating mammary gland was not
affected by the administration of BSO (results not shown).
Figure 7(A) shows that, in lactating rats injected with BSO, the
mammary gland undergoes apoptosis because the endonuclease
has been activated and a ladder pattern is seen when isolating DNA
from the mammary tissue. Figure 7(B) shows that the changes in
the different genes commented above were also reproduced when
GSH was depleted using BSO. Finally, in Figure 7(C), Western-
blot analyses show similar changes.
DISCUSSION
Milk production by the lactating mammary gland is dependent
on a complex interplay of lactogenic hormones and autocrine
effects due to suckling of the litter. Programmed cell death in
the mammary gland is associated with the expression of several
growth-arrest genes [18,19]. The Cip/Kip proteins (p21 and
p27), which inhibit all cyclin–cyclin-dependent kinase complexes
arresting the cell cycle [20], are overexpressed during weaning
and in rats injected with PPG and BSO, which shows that a low
availability of GSH to the gland of lactating rats is responsible in
part for the decline in lactation.
Other gene products which are found to be activated during the
early phase of involution are JNK and c-Jun (see Figures 3 and
4). An involvement of JNK in the activation of apoptosis has been
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Figure 6 Immunoblot analysis of p-JNK, c-Jun, p53, p21 and p27 in mammary tissue from control lactating rats and rats treated with PPG, NAC or both
Total extracts (50 µg of protein/lane) from mammary tissue of control rats, mammary PPG-, PPG + NAC- or NAC-treated rats, were electrophoresed and immunoblotted with specific antibodies for
pJNK, c-Jun, p53, p21 and p27. The graphs show the amount of each protein under the different conditions studied. Results are means +− S.E.M. for three different experiments. Different superscript
letters within a row indicate significant differences, P < 0.05.
previously documented [21]. c-Jun represents a major target for
JNK, and phosphorylation of c-Jun by JNK enhances its activity.
Activator protein-1 (AP-1) can trigger both pro- or anti-apoptotic
signals depending on the buffer composition, the cell types or the
death-inducing treatments [22]; the role of c-Jun in apoptosis is
thus complex, a function for AP-1 in apoptosis has initially been
proposed based on the observation that c-fos and c-jun mRNAs
are rapidly induced in cytokine-dependent lymphoid cells upon
growth-factor withdrawal [23]. The results of all of these studies
are in agreement with the increased expression found in JNK and
c-Jun in the weaned-pup glands and in the glands from PPG-
treated rats and BSO-treated rats.
Weaning also produces an induction of p53 expression,
resulting in cell arrest and apoptosis [24]; nevertheless, it has
been shown, using p53-deficient mice, that the involution of the
mammary epithelium takes place, but with a delay of several days.
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Figure 7 DNA fragmentation: RT-PCR analysis for c-Jun, p53 and p21 and
Western blot of p-JNK, c-Jun, p53, p27 and p21 in lactating rats treated over
a period of 2 days with BSO
(A) Agarose-gel electrophoresis of DNA from control lactating mammary gland, mammary tissue
obtained from rats injected with PPG over a period of 3 days and from mammary gland obtained
from rats treated with BSO over a period of 2 days. (B) Whole RNA isolated from mammary
gland was used for RT-PCR analysis of c-Jun, p53 and p21 from control lactating rats, from
rats treated with PPG and from rats treated over a period of 2 days with BSO. (C) Western-
blot analysis of proteins extracted from mammary glands (50 µg of protein/lane) from control
lactating rats, rats treated with PPG and rats treated with BSO, was done for phosphorylated
JNK, c-Jun, p53 and the Cip/Kip proteins p21cip1 and p27kip1.
In this type of null mice, the stromal proteases are induced in
the mammary gland by 5 days post-weaning, providing a p53-
independent mechanism for epithelial involution [24]. In the
present study, p53 levels (mRNA and protein) are high 2 h after
weaning begins (Figures 3 and 4), showing that this gene might
be responsible for the early changes at the onset of weaning. It
is noteworthy that the increased expression of p53 (mRNA and
protein levels) at the first hour of weaning is much higher at 2
and 24 h than at 4 and 8 h after weaning. This behaviour of p53
gene product remains to be investigated.
Using mice that contain a homozygous deletion of the oxytocin
gene, milk is retained in the alveolar lumens of the glands, owing
to the failure of milk ejection, although the pups remain suckling.
In this situation, PCD starts as a result of local factors, even in
the presence of systemic lactogenic hormones [4]. The possible
signals that bring about the increased p53 expression in the first
hours of weaning could be one of the following: (i) a decrease in
plasma lactogenic hormones after removal of pups, (ii) a lower
rate of delivery of hormones to the gland when compared with
control lactating rats, because lactating rats weaned for 5 h have a
marked fall in mammary-gland blood flow [25] that decreases
the levels of receptors for prolactin and oestrogens [26], and
(iii) milk accumulation. There are three stages of involution; the
first one is regulated locally by milk stasis, is p53-dependent and is
reversible. In this phase, apoptosis is promoted by the transcription
factor Stat3 (signal transduction and activators of transcription 3)
and transforming growth factor β3. Stat3 may induce apoptosis by
up-regulating a known promoter of apoptosis, insulin-like growth
factor-binding protein-5, and by down-regulating Stat5a [27]. The
second stage is also characterized by apoptosis, but it is mediated
by lactogenic hormones; finally, the third stage is a biosynthetic
phase in which mammary stroma is remodelled and repopulated
with adipose tissue [28].
There is in vitro evidence showing that GSH utilization by
the lactating mammary gland is mediated by γ -GGT. Using as an
experimental model bovine mammary acini, it has been shown that
the label from [35S]GSH is incorporated into the acid-precipitable
proteins when substrates are provided for protein synthesis. The
inclusion of a GGT inhibitor decreased the incorporation of 35S
into protein [29]. There is an inverse relationship between the
activities of GGT and γ -cystathionase in different mammalian
tissues [30]; the lactating mammary gland has a very high activity
of GGT and a non-detectable activity of γ -cystathionase. During
weaning, the activity of the GGT in the mammary gland is
significantly lower than in control lactating glands [31], and thus
GSH utilization and L-cysteine availability should decline during
mammary involution.
It has been shown in vivo that a high availability of GSH to the
lactating mammary gland is important to maintain lactation [2];
this happens because there is an increase GSH release by the liver,
the gland increases its size and the blood flow is also increased,
which assures a net supply of GSH to the gland. The signals
responsible for the high release of total glutathione by the liver of
lactating rats are the increase in protein intake, which modulates
the expression and activity of hepatic γ -cystathionase, and the
liver hypertrophy, which is unrelated to protein intake and is due to
physiological changes [2]. In the present work it is clearly shown
that, when GSH delivery to the gland is impaired, the mammary
gland undergoes similar changes to those that happen following
weaning. This emphasizes the importance of GSH availability
to GGT to provide a supply of L-cysteine needed to keep the
lactation and explains that the changes induced in the gland when
the liver trans-sulphuration pathway is inhibited with PPG are
partially reversed with NAC. It is noteworthy that the apoptotic
process evaluated by DNA fragmentation is induced when the
supply of L-cysteine as GSH is diminished and is partially reversed
when PPG-treated rats are injected simultaneously with NAC.
The experiments performed in BSO-treated rats show the same
results as PPG-treated rats. This points out the importance of GSH
homoeostasis in maintaining lactation.
Our results highlight that a decrease in GSH levels in vivo
induces apoptosis in the mammary gland. Different experimental
models have shown previously similar results using in vitro mo-
dels, but as far as we know this correlation found in vitro
has never been shown in whole tissue [32]. Recently, it has
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been shown that GSSG (oxidized glutathione) levels in lactating
mammary gland are higher during involution than at the peak
of lactation; a direct relationship between mtDNA damage and
the GSSG/GSH ratio has been revealed, but glutathione oxidation
precedes DNA fragmentation [6]. However, it remains unclear
whether high glutathione levels are essential to protect the tissue
against oxidative stress. Alternatively, glutathione could play
other undefined metabolic roles during the apoptotic process.
This work emphasizes the physiological importance of the
inter-tissue flux of GSH found in the lactating mother, because
it allows a delivery of L-cysteine to the mammary gland that is
required to maintain gene expression in this tissue.
This work was supported by grants from the Ministerio de Ciencia y Tecnolog´ıa y Plan
Nacional (I+D+I; BFI2001-2842; PM99-0148) and Instituto de Salud Carlos III, RCMN
(C03/08), Madrid, Spain. R.Z. and A.D.R. are supported by fellowships of the Ministerio
de Educacio´n y Cultura (Spain).
REFERENCES
1 Awata, S., Nakayama, K., Sato, A., Kawamura, M., Suzuki, Y. and Kodama, H. (1993)
Changes in cystathionase γ -lyase in rat liver during lactation. Biochem. Mol. Biol. Int.
31, 185–191
2 Barber, T., Triguero, A., Martinez-Lo´pez, I., Torres, L., Garc´ıa, C., Miralles, V. J. and
Vin˜a, J. R. (1999) Elevated expression of liver γ -cystathionase is required for the
maintenance of lactation in rats. J. Nutr. 129, 928–933
3 Tateishi, N., Higashi, T., Shinya, S., Naruse, A. and Sakamoto, Y. (1974) Studies on the
regulation of glutathione level in rat liver. J. Biochem. (Tokyo) 75, 93–103
4 Li, M., Liu, X., Robinson, G., Bar-Peled, U., Wagner, K.-U., Young, W. S.,
Hennighausen, L. and Furth, P. A. (1997) Mammary-derived signals activate programmed
cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci.
U.S.A. 94, 3425–3430
5 Strange, R., Metcalfe, T., Thackray, L. and Dang, M. (2001) Apoptosis in normal and
neoplastic mammary gland development. Microsc. Res. Tech. 52, 171–181
6 Esteve, J. M., Mompo´, J., Garc´ıa de la Asuncio´n, J., Sastre, J., Asensi, M., Boix, J.,
Vin˜a, J. R. and Pallardo´, F. V. (1999) Oxidative damage to mitochondrial DNA and
glutathione oxidation in apoptosis: studies in vivo and in vitro. FASEB J. 13, 1055–1064
7 Pias, E. K. and Aw, T. Y. (2002) Apoptosis in mitotic competent undifferentiated cells is
induced by cellular redox imbalance independent of reactive oxygen species production.
FASEB J. 16, 781–790
8 Washtien, W. and Abeles, R. (1977) Mechanism of inactivation of γ -cystathionase by the
acetylenic substrate analogue propargylglycine. Biochemistry 16, 2485–2491
9 Triguero, A., Barber, T., Garc´ıa, C., Puertes, I. R., Sastre, J. and Vin˜a, J. R. (1997) Liver
intracellular L-cysteine concentration is maintained after inhibition of the trans-
sulphuration pathway by propargylglycine. Br. J. Nutr. 78, 823–831
10 Brigelius, R., Muckel, C., Akerboom, T. P. M. and Sies, H. (1983) Identification and
quantitation of glutathione in hepatic protein mixed disulphides and its relationship to
disulphide. Biochem. Pharm. 32, 2526–2534
11 Heinonen, K. (1973) Studies on cystathionase activity in rat liver and brain during
development. Effects of hormones and amino acids in vivo. Biochem. J. 136, 1011–1015
12 Gaitonde, M. K. (1967) A spectrophotometric method for the direct determination of
cysteine in the presence of other naturally occurring amino acids. Biochem. J. 104,
627–633
13 Tate, S. S. and Meister, A. (1974) Interaction of gamma-glutamyltranspeptidase with
amino acids, dipeptides and derivates and analogs of glutathione. J. Biol. Chem. 249,
7592–7602
14 Sampson, D. A. and Jansen, G. R. (1984) Measurement of milk yield in the lactating rat
from pup weight gain. J. Pediatr. Gastroenterol. Nutr. 3, 613–617
15 Allen, R. T., Hunter, III, W. J. and Agrawal, D. K. (1997) Morphological and biochemical
characterization and analysis of apoptosis. J. Pharmacol. Toxicol. Methods 37, 215–228
16 Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid
guanidinium thiocyanate–phenol–chloroform extraction Anal. Biochem. 162, 156–159
17 Sherr, C. J. (2000) The Pezcoller Lecture: cancer cell cycles revisited. Cancer Res. 60,
3689–3695
18 Jaggi, R., Marti, A., Guo, K., Feng, Z. and Friis, R. R. (1996) Regulation of a physiological
apoptosis: mouse mammary involution. J. Dairy Sci. 79, 1074–1084
19 Gadd, M., Pisc, C., Branda, J., Ionescu-Tiba, V., Nikolic, Z., Yang, C., Wang, T.,
Shackleford, G. M., Cardiff, R. D. and Schmidt, E. V. (2001) Regulation of cyclin D1 and
p16INK4A is critical for growth arrest during mammary involution. Cancer Res. 61,
8811–8819
20 Muraoka, R., Lenferink, A. E. G., Simpson, J., Brantley, D. M., Roebuck, L. R., Yakes, F. M.
and Arteaga, C. L. (2001) Cyclin-dependent kinase inhibitor p27kip1 is required for mouse
mammary gland morphogenesis and function. J. Cell Biol. 153, 917–931
21 Marti, A., Lazar, H., Ritter, P. and Jaggi, R. (1999) Transcription factors activities and gene
expression during mouse mammary gland involution. J. Mammary Gland Biol. Neoplasia
4, 145–152
22 Mechta-Grigoriou, F., Gerald, D. and Yaniv, M. (2001) The mammalian Jun proteins:
redundancy and specificity. Oncogene 20, 2378–2389
23 Jochum, W., Passegue´, E. and Wagner, E. F. (2001) AP-1 in mouse development and
tumorigenesis. Oncogene 20, 2401–2412
24 Jerry, D. J., Dickinson, E. S., Roberts, A. L. and Said, T. K. (2002) Regulation of apoptosis
during mammary involution by the p53 tumor suppressor gene. J. Dairy Sci. 85,
1103–1110
25 Hanwell, A. and Linzell, J. L. (1973) The time course of cardiovascular changes in
lactation in the rat. J. Physiol. (London) 233, 11–125
26 Moore, B. P. and Forsyth, I. A. (1980) Influence of local vascularity on hormone receptors
in mammary gland. Nature (London) 284, 77–84
27 Chapman, R. S., Lourenco, P. C., Tonner, E., Flint, D. J., Selbert, S., Takeda, K., Akira, S.,
Clarke, A. R. and Watson, C. J. (1999) Suppression of epithelial apoptosis and delayed
mammary gland involution in mice with a conditional knock out of Stat3. Genes Dev. 13,
2604–2616
28 Wiseman, B. S. and Werb, Z. (2002) Stromal effects on mammary gland development and
breast cancer. Science 296, 1046–1049
29 Baumrucker, C. R., Pocius, P. A. and Riss, T. (1981) Glutathione utilization by lactating
bovine mammary secretory tissue in vitro. Biochem. J. 198, 243–246
30 Hirai, M., Iwamura, S., Varghese, G., Speisky, H. and Israel, Y. (1994) Reciprocal
γ -glutamyl transferase and cystathionase activity in guinea pig, rat and human liver.
J. Hepatology 21, 683–688
31 Vin˜a, J. R., Puertes, I. R. and Vin˜a, J. (1981) Effect of premature weaning on amino acid
uptake by the mammary gland of lactating rats. Biochem. J. 200, 705–708
32 Ratan, R. R. and Baraban, J. M. (1995) Apoptotic death in an in vitro model of neuronal
oxidative stress. Clin. Exp. Pharmacol. Physiol. 22, 309–310
Received 11 March 2003/11 April 2003; accepted 1 May 2003
Published as BJ Immediate Publication 1 May 2003, DOI 10.1042/BJ20030387
c© 2003 Biochemical Society
